Delhi HC Orders Action Against Spurious Oxytocin Use In Dairy Colonies

New Delhi: The Delhi High Court has ordered State authorities to take action against the spurious use of oxytocin on cattle in dairy colonies in the Capital. It noted that administering the hormone, which results in increased milk production, amounts to animal cruelty and is, therefore, an offence.

The court asked the Delhi government’s Department of Drugs Control to conduct weekly inspections and register cases against the administration of the hormone. These cases will be investigated by the police.

It further asked the Delhi police to identify the sources of oxytocin production, packaging and distribution, and take action in accordance with the law.

The court’s order on Wednesday came after a petition appealed to authorities to look into the state of dairies in the Capital.

In March 2023, the High Court had constituted a court commissioner for inspecting nine dairy colonies in the Capital. The court commissioner had flagged the “rampant use” of oxytocin.

“Since administering oxytocin amounts to animal cruelty and is a cognisable offence under Section 12 of The Prevention of Cruelty to Animals Act, 1960, consequently, this Court directs the Department of Drugs Control, GNCTD to conduct weekly inspections,” the court ordered.

The court commissioner also stated that the conditions in all the nine designated dairy colonies in Delhi – Kakrola Dairy, Goela Dairy, Nangli Shakrawati Dairy, Jharoda Dairy, Bhalaswa Dairy, Ghazipur Dairy, Shahbad Daulatpur Dairy, Madanpur Khadar Dairy and Masoodpur Dairy are bad.

The court, however, said there is urgent need to rehabilitate and relocate the Ghazipur Dairy and Bhalswa Dairy forthwith as they are located next to the sanitary landfill sites.

“Cattle in the dairies situated next to the landfill sites without doubt would feed on hazardous waste and their milk if consumed by humans, particularly children, (directly or indirectly) could have serious consequences,” the High Court said.

The court also opined that the dairies should be relocated in areas having proper sewage, drainage, biogas plant and ample open space for the grazing of the cattle.

However, before issuing any binding direction, the court said it would like to hear from the concerned officials as to how these directions should be implemented.

“For this purpose, the Commissioner (MCD), Director of Veterinary (MCD), Chief Secretary (GNCTD), CEO (DUSIB) and CEO (FSSAI) are directed to join the proceedings by way of an audio-video link on the next date of hearing,” the High Court said.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre